1. Home
  2. TIC vs IMNM Comparison

TIC vs IMNM Comparison

Compare TIC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TIC

Acuren Corporation

HOLD

Current Price

$9.51

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$24.77

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIC
IMNM
Founded
1991
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TIC
IMNM
Price
$9.51
$24.77
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$14.63
$31.22
AVG Volume (30 Days)
2.3M
2.0M
Earning Date
03-27-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,284,070,000.00
$9,679,000.00
Revenue This Year
$41.97
N/A
Revenue Next Year
$42.94
$11.53
P/E Ratio
N/A
N/A
Revenue Growth
16.15
N/A
52 Week Low
$8.76
$5.15
52 Week High
$14.94
$27.65

Technical Indicators

Market Signals
Indicator
TIC
IMNM
Relative Strength Index (RSI) 28.12 57.35
Support Level $8.90 $23.86
Resistance Level $10.21 $27.65
Average True Range (ATR) 0.46 1.63
MACD -0.22 -0.08
Stochastic Oscillator 3.10 62.94

Price Performance

Historical Comparison
TIC
IMNM

About TIC Acuren Corporation

TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: